Leukocyte extravasation into perivascular tissue during inflammation and lymphocyte homing to lymphoid organs involve transient adhesion to the vessel endothelium, followed by transmigration through the endothelial cell (EC) layer and establishment of residency at the tissue site for a period of time. In these processes, leukocytes undergo multiple attachments to, and detachments from, the vessel-lining endothelial cells, prior to transendothelial cell migration. Transmigrating leukocytes must traverse a subendothelial basement membrane en route to perivascular tissues and utilize enzymes known as matrix metalloproteinases to make selective clips in the extracellular matrix components of the basement membrane. This review will focus on the evidence for a link between adhesion of leukocytes to endothelial cells, the induction of matrix metalloproteinases mediated by engagement of adhesion receptors on leukocytes, and the ability to utilize these matrix metalloproteinases to facilitate leukocyte invasion of tissues. Leukocytes with invasive phenotypes express high levels of MMPs, and expression of MMPs enhances the migratory and invasive properties of these cells. Furthermore, MMPs may be used by lymphocytes to proteolytically cleave molecules such as adhesion receptors and membrane bound cytokines, increasing their efficiency in the immune response. Engagement of leukocyte adhesion receptors may modulate adhesive (modulation of integrin affinities and expression), synthetic (proteinase induction and activation), and surface organization (clustering of proteolyric complexes) behaviors of invasive leukocytes. Elucidation of these pathways will lead to better understanding of controlling mechanisms in order to develop rational therapeutic approaches in the areas of inflammation and autoimmunity.
INTRODUCTION Leukocyte Extravasation
During the processes of homing and extravasation at sites of inflammation, circulating leukocytes become tissue-resident cells for variable periods of time. The transmigration of leukocytes from the bloodstream into perivascular tissue is a critical event in both these processes. During homing, lymphocytes bind to adhesion receptors displayed on high endothelial venules (HEV) as points of entry into secondary lymphoid * Supported, in Part by USPHS Grant RO 1-HL-51018 to JAM.
? All correspondence to: Joseph A. Madri CT 06510. TEL: 203-785-2763, FAX: 203-785-7373. 104 JOSEPH A. MADRI and DONNASUE GRAESSER organs (except spleen where lymphocytes enter via blood sinusoids in the marginal zones). Granulocytes and monocytes do not home but, along with lymphocytes, will adhere to the microvascular endothelium in inflamed tissues, and in response to chemoattractant or adhesive gradients, migrate across the endothelial cell layer and accumulate at the site of injury or infection. Both the processes of homing and extravasation during inflammation are dynamic, involving multiple attachments to, and detachments from, a variety of cell types and extracellular matrix components, before encountering antigen or antigen-presenting cells in the tissues and delivering an appropriate immunological response. The general mechanisms involved in both processes are similar (Reviewed in Springer, 1995a Springer, , 1995b . Briefly, the extravasating leukocytes will first be tethered to the endothelial cells, roll along the blood vessel wall, integrins on the cell surface will be activated and used to adhere tightly to the endothelial cells, leukocytes will transmigrate across the endothelial layer, traverse the subendothelial basement membrane, and finally migrate into the perivascular tissue. All these steps are mediated by binding of adhesion molecules on the extravasating leukocytes to counter-receptors on endothelial cells lining the vessel wall.
Initial tethering and rolling of leukocytes on the vessel wall are mediated by a class of molecules known as selectins, which form labile adhesions that permit leukocytes to subsequently roll in the direction of flow (Lawrence and Springer, 1991; Lawrence and Springer, 1993; vonAndrian, 1991) . Selectins appear to recognize sialylated carbohydrate determinants on their counter-receptors (Berg et al., 1991; Lasky, 1992;  Rosen, 1993) . L-selectin (LAM-1, MEL-14, is expressed on all circulating leukocytes, except for a subpopulation of lymphocytes (Gallatin et al., 1983; Kansas et al., 1985; Lewinsohn et al., 1987) and recognizes at least 2 mucin-like molecules on HEV, GlyCAM-1 and CD34 (Baumhueter et al., 1993 (Baumhueter et al., , 1994 . CD34 is also expressed on capillaries but is absent from most large vessels (Fina et al., 1990) . Conversely, leukocytes can bind to E-selectin (ELAM-1) or P-selectin expressed on endothelial cells at inflammatory sites. E-selectin is induced on microvascular endothelial cells in response to cytokines such as IL-1, LPS, or TNF-o (Bevilacqua et al., 1987) . Endothelial cell P-selectin is stored in Weibel Palade bodies and rapidly mobilized to the plasma membrane to bind neutrophils and monocytes in response to mediators of acute inflammation (Geng et al., 1990; Larsen et al., 1989; McEver et al., 1989 ). E-and P-selectin recognize distinct, but closely related ligand structures (Alon et al., 1995; Larsen et al., 1992) . A rapid selectin-ligand association rate facilitates the initial tethering, and a rapid dissociation rate allows the leukocyte to roll forward (Lawrence and Springer, 1991; Hammer and Apte, 1992 (Hemler, 1990; Hynes, 1992 and Springer, 1987; Rothlein et al., 1986; Shimizu et al., 1991; Staunton et al., 1989) as well as (aM[32 integrin, CDllb/CD18) on neutrophils and monocytes (Diamond et al., 1990 (Diamond et al., , 1991 . VCAM-1 (Vascular Cell Adhesion Molecule, CD 106) on endothelial cells binds both (o4[1 integrin, CD49d/CD29) and cz4137 integrin on leukocytes (Chan et al., 1992; Elices et al., 1990; Osborne et al., 1989; Ruegg et al., 1992; Shimizu et al., 1991; Vennegoor et al., 1992) . VLA-4 integrin also binds to the alternatively spliced CS-1 peptide of the extracellular matrix glycoprotein fibronectin (Wayner et al., 1989) . In addition, during lymphocyte recirculation to mucosal tissues, the mucosal addressin, MAdCAM-1, on Peyer's patch HEV binds cz47, but not cz4l, integrin (Berlin et al., 1993 (Newman et al., 1990; Albelda et al., 1990 Albelda et al., , 1991 and is thought to interact in a homophilic manner during T cell-endothelial cell interactions (Bogen et al., 1992) . PECAM-1 has been shown to participate in transendothelial migration and migration through extracellular tissues by neutrophils, natural killer cells, and monocytes (Berman et al., 1996; Christofidou-Solomidou et al., 1997; Liao et al., 1995; Liao et al., 1997; Muller, 1995) .
Integrins must be activated in order to bind to the appropriate ligands (Diamond and Springer, 1994) . Activation may be regulated by a number of extracellular signals including cross-linking of the antigen receptor, phorbol esters, binding to complement components or to fibrinogen, or other cell-cell adhesive interactions (Arroyo et al., 1993; Berman and Muller, 1995; Berman et al., 1996; Smith et al., 1989; Tanaka et al., 1992; Wilkins et al., 1991) . During rolling, leukocytes come into contact with chemoattractants on the microvascular endothelium, which bind G-protein coupled receptors on leukocytes (Miller and Krangel, 1992; Springer, 1995a Springer, , 1995b and stimulate changes such as degranulation, shape change, actin polymerization, and respiratory burst, as well as activating the adhesiveness of integrin molecules (Lo et al., 1989; Smith et al., 1991) . Adhesiveness of integrin molecules such as Mac-1 and LFA-1 on neutrophils and monocytes is activated by chemokines including N-formylated peptide and IL-8. Increased adhesiveness is not due to changes in expression, but is likely due to conformational changes that increase their affinity for endothelial cell ligands (Diamond and Springer, 1994; Landis et al., 1993; Lollo et al., 1994) . Integrin adhesiveness is transient and is down-regulated within minutes Lo et al., 1989) . This cycling between adhesive and non-adhesive states allows the cells to rapidly regulate adhesion to ligands on opposing cell surfaces and matrices (Diamond and Springer, 1994 . Leukocyte migration through the ECM is mediated by a number of parameters including integrin surface expression (Graesser et al., 1998; Juliano & Haskill, 1993; Leavesly et al., 1994; Romanic & Madri, 1994; Romanic et al., 1997; Shimizu & Shaw, 1991) ;
integrin affinity (Arroyo et al, 1993; Hourihan et al., 1993; Shimizu & Shaw, 1991; Smith et al., 1989; Wilkins et al., 1991) ; ECM synthesis and deposition (Hauser et al., 1993; Madri et al., 1988) ; and ECM degradation (Goetzl et al., 1996; Graesser et al., 1998; Leppert et al., 1995a Leppert et al., , 1195b Leppert et al., , 1996 Montgomery et al., 1993; Romanic & Madri, 1994) . In this review we will discuss the contributions and inter-relationships of integrin engagement and matrix metalloproteinases in the transition of leukocytes, in particular T lymphocytes, from circulating cells to tissue resident cells.
Matrix metalloproteinases in leukocytes
Even with the precise combination of adhesion molecules and chemokines, not all cells acquire a migratory phenotype and become invasive. Several studies have implicated MMPs as an important component in tumor cell migration and tissue invasion (Fessler et al., 1984; H6yhtyi et al., 1990; Liotta et al., 1979; Mignatti et al., 1986; Salo et al., 1983 (Goetzl et al., 1996; Leppert et al., 1995a Leppert et al., , 1995b Leppert et al., , 1996 Xia et al., 1996a Xia et al., , 1996b (Graesser et al., 1998; Hynes, 1992; Romanic & Madri, 1994; Romanic et al., 1997; Shimizu And Shaw, 1991) . For instance, engagement of VLA-4 either with antibodies to the c4 subunit or with the alternatively spliced CS domain of fibronectin has been shown to stimulate tyrosine phosphorylation of a 150 kDa protein in T cells (Nojima et al., 1992 (Romanic & Madri, 1994; Romanic et al., 1997) . In addition, engagement of the VLA-5 integrin on T cells with fibronectin has been shown to induce the expression of the AP-1 transcription factor which regulates IL-2 transcription (Yamada et al., 1991) .
Recent data suggests that integrin-mediated signals may also regulate MMP secretion and/or activity in a number of cell types. For each cell type examined, there appears to be some degree of specificity, ie. only certain integrin engagements will induce particular MMPs. In several tumor cell models, integrins have been shown to play a role in transducing signals that either enhance the expression of matrix metalloproteinases, their inhibitors, or their activators (Remy et al., 1999) . In human rhabdomyosarcoma cells, antibodies against 2 and c3 integrin subunits enhanced the secretion of MMP-2, activation of the enzyme, and subsequent invasion of matrigel by the cells (Kubota et al., 1998) . Ligation of c6[1 integrin on a human melanoma cell line promoted invasiveness by causing a 2-3 fold increase in ECM degradation (Nakahara et al., 1996) . The induced ECM degradation was associated with increased surface expression of a gelatinase enzyme, and localization of the gelatinase at invadopodia. In a similar assay, invasion of matrigel by human glioma cells was increased by treatment with antibodies against either 31 integrin or 5[1 integrin (Chintala et al., 1996) , which also resulted in decreased expression of these integrins and increased expression of MMP-2. Engagement of 51 integrin by binding the RGD peptide fragment of fibronectin was found to induce stromelysin, collagenase, and MMP-9, and increase the expression of MMP-2 in rabbit articular chondrocytes (Arner and Tortorella, 1995) . cv3 and c5[1 integrins have been shown to play a role in human melanoma cell invasion by regulating expression of MMP-2 (Seftor et al., 1992 (Seftor et al., , 1993 . Induction of MMPs via integrin-mediated signals has been observed in non-cancerous cells as well.
Binding of chondrocytes to RGD peptide has been shown to induce the synthesis of stromelysin, MMP-1, MMP-9 and increase the expression of MMP-2. (Arner and Tortorella, 1995) . In fibroblasts, the expression of several MMPs is regulated by adhesion to fibronectin (Huhtala et al., 1995; and tenascin (Tremble et al., 1994) . Additionally, recent studies in our lab have shown that MMPs induced via integrin-mediated signals play a role in both in vivo and in vitro models for T cell transmigration (Baron et al., 1993; Graesser et al., 1998; Romanic and Madri, 1994) .
In It is likely that induction of MMP-2 is at least one major role for 4 integrin in the disease process, as inhibitors of MMP-2 significantly delay the onset of disease (Graesser et al., 1998) . Other investigators observed similar effects of MMP inhibitors on EAE disease progression in both mouse (Gijbels et al., 1994) and rat (Hewson et al., 1995) (Anthony et al., 1998) . Together, these data suggest that regulation of expression and/or activation of MMPs plays a role in several models of T lymphocyte invasion into the CNS in vivo.
A role in T cell transmigration in vitro?
While informative, many times animal models frequently do not lend themselves to mechanistic studies. We and others have utilized in vitro models in which T cells are co-cultured on a monolayer of endothelial cells and/or subendothelial matrix, mimicking the in vivo situation of blood vessel endothelium and subendothelial basement membrane. In this model, T cells transmigrate through the endothelial Cell monolayer and subendothelial matrix, through a porous membrane and into a collection well. In these studies, both 4 integrin high-expressing and integrin low-expressing T cell clones adhered well to both VCAM-1 positive and VCAM-negative endothelial cells (70% to 90%). However, high levels of T cell transmigration were observed only when T cells expressed significant levels of 4 integrin and endothelial cells expressed VCAM-1, suggesting that 41 integrin engagement is necessary for T cell transmigration (Graesser et al., 1998, Romanic and Madri, 1994) . Furthermore, these studies suggest an inter-relationship between the presence and engagement of c4l]l and the induction and activation of MMP-2 during the process of T cell transmigration, because specific inhibitors of MMP-2 will block the high level of transmigration conferred by c4ll integrin expression. Using similar in vitro models, other groups have also found that MMP inhibitors significantly reduce transmigration of lymphocytes (Leppert et al., 1995a (Leppert et al., , 1995b Xia et al., 1996a) .
Further evidence for the importance of integrin-mediated MMP regulation in T lymphocyte transmigration comes from studies with human peripheral blood T cells (Xia et al., 1996b (Yong et al., 1998) .
Organization of proteolytic complexes on T cell surfaces" A pre-requisite for transmigration?
In several recent studies investigators have demonstrated the concentration of surface-bound proteinases on specific areas of migrating cells (Basbaum and Werb, 1996; Chen, 1996; Monsky et al., 1994; Nakahara et al., 1996) In recent studies we have observed a similar phenomenon in T cells which have adhered to and are initiating their migration through an endothelial cell monolayer and underlying matrix (Figure 1 ).
Prior to adhesion to endothelial cell surfaces, o4[1 positive T cells express MT1-MMP and TIMP-2 on their surface in diffuse patterns. However, at early times following adhesion, o4[1 positive T cells are seen to express MMP-2 on their cell surface, co-localized with both MT1-MMP and TIMP-2. All three of the molecules in the "activation complex" are polarized to extended podosome regions on the migrating cells, as illustrated in Figure 1 . We hypothesize that these regions will become the putative invading podosomes (invadopodiae) of the migrating T cells (Graesser, Mahooti and Madri, in preparation) . These observations suggest a complex, multipoint control system for induction, secretion, surface tethering and activation of MMP-2 on the T cell surface. The generation, isolation and characterization of T cell clones having specific alterations in this migration pathway is likely to facilitate a more complete elucidation of this process in T cells as well as in other cell types. Thus, the cellular mechanism(s) mediating this process are currently undefined, but could involve activation and organization of the cytoskeleton, potentially triggered by specific integrin (o411 and/or other integrins) engagement and signaling as illustrated in Figure 1 . . The physiologic L-selectin "sheddase" enzyme is believed to be a metalloproteinase, as shedding is completely prevented by hydroxymate-based metalloproteinase inhibitors (Preece et al., 1996; Bennett et al., 1996) . In addition, L-selectin is susceptible to cleavage by known matrix metalloproteinases, MMP-1 and MMP-3. However, MMP-2 and MMP-9 have no effect, and L-selectin shedding is not inhibited by TIMPs. Shedding of L-selectin is thought to be an important part of the rolling mechanism, and L-selectin-mediated leukocyte rolling is slowed by preventing shedding (Hafezi-Maghadam and Ley, 1999; Walcheck et al., 1996) kDa gelatinase). This is followed by formation and clustering of a tertiary complex comprised of MT1-MMP, TIMP-2 and pro-MMP-2 and activation of MMP-2. In addition, these T cells exhibit reduced adhesion to VCAM-1 and ICAM-1 and increased adhesion to collagen types and IV, fibronectin and laminin. Also noted were increases in endothelial cell uPA expression and activity and decreases in endothelial cell
